Cargando…

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients

The widespread prevalence of coronavirus disease-2019 (COVID-19) which is caused by severe respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has resulted in a severe global public health emergency. However, there are no sensitive biomarkers to predict the disease prognosis of COVID-19 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lili, Li, Jie, Gao, Meiling, Fan, Huimin, Wang, Yanan, Xu, Xin, Chen, Chunfeng, Liu, Junxiao, Kim, Jocelyn, Aliyari, Roghiyh, Zhang, Jicai, Jin, Yujie, Li, Xiaorong, Ma, Feng, Shi, Minxin, Cheng, Genhong, Yang, Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820901/ https://www.ncbi.nlm.nih.gov/pubmed/33488599 http://dx.doi.org/10.3389/fimmu.2020.602395

Ejemplares similares

Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2
por: Li, Lili, et al.
Publicado: (2022)

GOLM1 suppresses autophagy-mediated anti-tumor immunity in hepatocellular carcinoma
por: Sui, Tianqi, et al.
Publicado: (2021)

HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells
por: Li, Lili, et al.
Publicado: (2023)

Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagens
por: Liu, Wancheng, et al.
Publicado: (2021)

A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling
por: Parvatiyar, Kislay, et al.
Publicado: (2018)

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
por: Liu, Tao, et al.
Publicado: (2020)

Anti-Interleukins for Severe Coronavirus Disease-2019: Hype or Hope?
por: Dimosiari, Athina, et al.
Publicado: (2022)

Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
por: Huang, Lan, et al.
Publicado: (2020)

ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12
por: Li, Lili, et al.
Publicado: (2021)

Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation
por: Tan, Guangyun, et al.
Publicado: (2019)

Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
por: Li, Chunfeng, et al.
Publicado: (2017)

Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis
por: Deimel, Lachlan Paul, et al.
Publicado: (2021)

Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019
por: Li, Diangeng, et al.
Publicado: (2020)

Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)

Elevated interleukin‐6, interleukin‐10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
por: Godkin, Andrew, et al.
Publicado: (2020)

Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Interferon-Inducible Cholesterol-25-Hydroxylase Inhibits Hepatitis C Virus Replication via Distinct Mechanisms
por: Chen, Yongzhi, et al.
Publicado: (2014)

Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy
por: Schwab, Kristin, et al.
Publicado: (2020)

Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect
por: Shi, Mei-jing, et al.
Publicado: (2021)

Soluble interleukin-2 receptor levels on admission associated with mortality in coronavirus disease 2019
por: Kaya, Hiroyasu, et al.
Publicado: (2021)

Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
por: Li, Chunfeng, et al.
Publicado: (2020)

Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
por: Majeed, Abdulraheem Y., et al.
Publicado: (2023)

Coronavirus disease 2019 in pregnancy
por: Qiancheng, Xu, et al.
Publicado: (2020)

Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
por: Zu, Shulong, et al.
Publicado: (2021)

„Coronavirus disease 2019“
por: Kerbl, Reinhold, et al.
Publicado: (2021)

Coronavirus Disease 2019
por: Lin, Sophie, et al.
Publicado: (2021)

Feasibility of coronavirus disease 2019 eradication
por: Zheng, Ya-Li, et al.
Publicado: (2020)

Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists
por: Jin, Huijuan, et al.
Publicado: (2020)

Early prediction model for progression and prognosis of severe patients with coronavirus disease 2019
por: Liu, Li, et al.
Publicado: (2021)

Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge
por: Liang, Limei, et al.
Publicado: (2020)

A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level
por: Hambali, Nurfarah Lydia, et al.
Publicado: (2020)

In Vitro–Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019
por: Mazer, Monty B., et al.
Publicado: (2021)

Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Aarskog, Nikolai Ravn, et al.
Publicado: (2021)

Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)
por: Ahmed, Aeshah A., et al.
Publicado: (2021)

From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
por: Farinetti, Alberto, et al.
Publicado: (2022)

The prognostic significance of electrocardiography findings in patients with coronavirus disease 2019: A retrospective study
por: Yang, Deyan, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19): current status and future perspectives
por: Li, Heng, et al.
Publicado: (2020)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
por: Ouyang, Jing, et al.
Publicado: (2020)

Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma
por: Kong, Yujie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hlb1lhhkoof4o2q55l71vff17r